20822 Federal Register / Vol. 66, No. 80 / Wednesday, April 25, 2001 / Notices

Abuse and Alcoholism, National Institutes of

Health, Suite 409, 6000 Executive Boulevard,

Bethesda, MD 20892–7003, 301–443–2861.

This notice is being published less

than 15 days prior to the meeting due

to the timing limitations imposed by the

review and funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Center Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: April 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10200 Filed 4–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Initial Review Group Kidney, Urologic and

Hematologic Diseases D Subcommittee.

Date: June 15, 2001.

Open: 8 a.m. to 8:30 a.m.

Agenda: To review procedures and discuss

policies.

Place: Doubletree Hotel, 300 Army Navy

Drive, Arlington, VA 22202.

Closed: 8:30 a.m. to adjournment.

Agenda: To review and evaluate grant

applications.

Place: Doubletree Hotel, 300 Army Navy

Drive, Arlington, VA 22202.

Contact Person: Neal A. Musto, PhD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Room 750, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MD 20892–6600, (301)

594–7798, muston@extra.niddk.nih.gov.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Initial Review Group Diabetes,

Endocrinology and Metabolic Diseases B

Subcommittee.

Date: June 19, 2001.

Open: 7 a.m. to 8 a.m.

Agenda: Discuss committee activities.

Place: Holiday Inn, 1450 Glenarm Place,

Denver, CO 80202.

Closed: 8 a.m. to adjournment.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, 1450 Glenarm Place,

Denver, CO 80202.

Contact Person: Michele L. Barnard, PhD,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, National Institutes of

Health, Room 657, 6707 Democracy

Boulevard, Bethesda, MD 20892, (301) 594-

8898.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: April 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10201 Filed 4–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Telemedicine’’.

Date: May 8, 2001.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 301–435–1437.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Transdermal THC’’ and ‘‘Development of

Placebo Marijuana Cigarettes’’.

Date: May 10, 2001.

Time: 10 a.m. to 2 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 301–435–1437.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health,

HHS).

Dated: April 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10202 Filed 4–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Advisory Environmental

Health Sciences Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should